GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Diamond Biofund Inc (TPE:6901) » Definitions » Change In Receivables

Diamond Biofund (TPE:6901) Change In Receivables : NT$-0.46 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Diamond Biofund Change In Receivables?

Diamond Biofund's change in receivables for the quarter that ended in Sep. 2024 was NT$1.59 Mil. It means Diamond Biofund's Accounts Receivable declined by NT$1.59 Mil from Jun. 2024 to Sep. 2024 .

Diamond Biofund's change in receivables for the fiscal year that ended in Dec. 2022 was NT$-0.18 Mil. It means Diamond Biofund's Accounts Receivable increased by NT$0.18 Mil from Dec. 2021 to Dec. 2022 .

Diamond Biofund's Accounts Receivable for the quarter that ended in Sep. 2024 was NT$0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Diamond Biofund's liquidation value for the three months ended in Sep. 2024 was NT$5,813.66 Mil.

Diamond Biofund Change In Receivables Historical Data

The historical data trend for Diamond Biofund's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamond Biofund Change In Receivables Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Change In Receivables
-1.86 7.96 0.17 -0.18

Diamond Biofund Quarterly Data
Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24 Jun24 Sep24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.57 -1.49 1.59

Diamond Biofund Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamond Biofund  (TPE:6901) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Diamond Biofund's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0*91
=

2. In Ben Graham's calculation of liquidation value, Diamond Biofund's accounts receivable are only considered to be worth 75% of book value:

Diamond Biofund's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=5999.488-185.825+0.75 * 0+0.5 * 0
=5,813.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamond Biofund Change In Receivables Related Terms

Thank you for viewing the detailed overview of Diamond Biofund's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamond Biofund Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Diamond Biofund Inc (TPE:6901) » Definitions » Change In Receivables
Comparable Companies
ROCO:7777 BLK KKR BX APO TSX:BN OSTO:INVE A AMP LSE:III ARES XSWX:PGHN OSTO:EQT RJF STT TROW XAMS:CVC TSX:BAM BOM:543940 NTRS CG
Traded in Other Exchanges
N/A
Address
No. 236, Section 4, Xinyi Road,, 11th Floor, Daan District, Taipei City, TWN, 106047
Website
https://www.diamondbiofund.com
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting global and internationally competitive investment targets, including new drug research and development, high-end medical equipment, innovative medical service technology, medical access, agricultural biotechnology.

Diamond Biofund Headlines

No Headlines